Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Tokorozawa-Shi, Japan Clinical Trials

A listing of Tokorozawa-Shi, Japan clinical trials actively recruiting patients volunteers.


Found (1) clinical trials

Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

This is a Phase 1, multicenter, open-label study to evaluate safety, tolerability and pharmacokinetics of milademetan in Japanese patients with relapsed or refractory acute myeloid leukemia. The milademetan initial dose will be Level 1: 90 mg. No increase in the milademetan dose will be made in the same participant. Dose-limiting ...


7.38 miles

Learn More »